← Evidence map

ArticleDrug safety2022

Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".

Daniel C Malone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022

this papercites it

Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)". | OpenQuestion